Long-acting Inhaled Bronchodilator and Risk of Vascular Events in Patients With Chronic Obstructive Pulmonary Disease in Taiwan Population

A combination of long-acting anticholinergic agents (LAACs) and long-acting β(2)-adrenergic receptor agonist (LABA) is effective in improving lung function in chronic obstructive pulmonary disease (COPD) compared with monotherapy. However, evidence on whether this combination increases the incidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Ming-Jun, Chen, Chung-Yu, Huang, Yaw-Bin, Chao, Hsiao-Chung, Yang, Chih-Jen, Lin, Pei-Jin, Tsai, Yi-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
6700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697980/
https://www.ncbi.nlm.nih.gov/pubmed/26705214
http://dx.doi.org/10.1097/MD.0000000000002306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697980/
https://www.ncbi.nlm.nih.gov/pubmed/26705214
http://dx.doi.org/10.1097/MD.0000000000002306

Ejemplares similares